We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$3.74B
AUM Growth
+$522M
Cap. Flow
+$560M
Cap. Flow %
14.98%
Top 10 Hldgs %
16.36%
Holding
2,890
New
823
Increased
552
Reduced
580
Closed
639

Sector Composition

Rank Sector Weight
1 Financials 10.6%
2 Healthcare 10.46%
3 Industrials 9.64%
4 Consumer Discretionary 7.06%
5 Technology 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VST icon
151
Vistra
VST
$52.8B
$4.57M 0.12%
196,466
+163,703
+500% +$3.63M
PCGU
152
DELISTED
PG&E Corporation
PCGU
$4.51M 0.12%
+40,000
New +$4.5M
ENTA icon
153
Enanta Pharmaceuticals
ENTA
$378M
$4.49M 0.12%
63,046
+33,846
+116% +$2.2M
PLAN
154
DELISTED
Anaplan, Inc.
PLAN
$4.47M 0.12%
68,772
+50,781
+282% +$2.47M
TWOU
155
DELISTED
2U Inc
TWOU
$4.44M 0.12%
11,137
+388
+4% +$156K
PTEN icon
156
Patterson-UTI
PTEN
$3.67B
$4.43M 0.12%
285,966
-46,498
-14% -$587K
WAL icon
157
Western Alliance Bancorporation
WAL
$9.21B
$4.34M 0.12%
+52,357
New +$5.12M
BSX icon
158
Boston Scientific
BSX
$68.7B
$4.31M 0.12%
97,399
-60,244
-38% -$2.61M
TVTX icon
159
Travere Therapeutics
TVTX
$5.38B
$4.29M 0.11%
166,520
+123,425
+286% +$3.28M
HLLY.WS
160
DELISTED
Holley Inc Warrants
HLLY.WS
$4.28M 0.11%
1,029,407
+331,198
+47% +$1.18M
ITCI
161
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.27M 0.11%
69,719
+51,841
+290% +$2.69M
AEE icon
162
Ameren
AEE
$31.2B
$4.21M 0.11%
44,915
-33,429
-43% -$2.93M
SRPT icon
163
Sarepta Therapeutics
SRPT
$1.72B
$4.17M 0.11%
53,361
+31,488
+144% +$2.41M
AMED
164
DELISTED
Amedisys
AMED
$4.15M 0.11%
24,097
-150
-0.6% -$22.4K
EXC icon
165
Exelon
EXC
$48.6B
$4.13M 0.11%
86,820
-108,424
-56% -$4.59M
WIX icon
166
WIX.com
WIX
$2.34B
$4.1M 0.11%
+39,216
New +$4.28M
COHR
167
DELISTED
Coherent Inc
COHR
$4.08M 0.11%
14,931
-214
-1% -$56K
AVTR icon
168
Avantor
AVTR
$8.11B
$4.04M 0.11%
+119,388
New +$4.26M
CRNX icon
169
Crinetics Pharmaceuticals
CRNX
$8.89B
$4.03M 0.11%
183,543
+95,935
+110% +$1.94M
CLF icon
170
Cleveland-Cliffs
CLF
$6.76B
$4.03M 0.11%
+124,999
New +$2.85M
ATEC icon
171
Alphatec Holdings
ATEC
$1.34B
$4.01M 0.11%
348,547
+131,930
+61% +$1.43M
UTHR icon
172
United Therapeutics
UTHR
$26.6B
$4.01M 0.11%
22,341
+20,332
+1,012% +$3.87M
EPAY
173
DELISTED
Bottomline Technologies Inc
EPAY
$3.99M 0.11%
70,426
+36,057
+105% +$2.04M
NTAP icon
174
NetApp
NTAP
$32.7B
$3.98M 0.11%
47,963
+20,760
+76% +$1.81M
FIVE icon
175
CALL
Five Below
FIVE
$11.5B
$3.96M 0.11%
+25,000
New +$4.17M

Similar funds

Walleye Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Walleye Capital held 2,890 positions worth $3.74B, up 16% from $3.22B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Walleye Capital deployed $560M of net new capital in Q1 2022, opening 823 new positions and adding to 552 existing holdings. Its largest new stake was Otis Worldwide: 278,870 shares worth $21.5M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 8.5% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Expand Energy Corp Class A Warrants, an estimated $32.4M trimmed.

  • Walleye Capital's largest Q1 2022 buy was Otis Worldwide: 278,870 shares worth $21.5M.
  • Walleye Capital added most to Expand Energy Corp Class B Warrants in Q1 2022, an estimated $38.1M increase.
  • Walleye Capital's biggest Q1 2022 reduction was Expand Energy Corp Class A Warrants, cutting an estimated $32.4M.
  • Walleye Capital fully exited Rockwell Automation in Q1 2022, selling an estimated $19.6M.
  • Walleye Capital's ten largest holdings make up 16% of its $3.74B portfolio in Q1 2022.
  • Walleye Capital opened 823 new positions and closed 639 in Q1 2022.
  • Walleye Capital's portfolio value rose 16% quarter-over-quarter to $3.74B.

Based on Walleye Capital's 13F filing for Q1 2022, filed 16 May 2022.